State-of-the-Art Management of Pituitary and Neuroendocrine Disorders

Transcription

1 State-of-the-Art Management of Pituitary and Neuroendocrine Disorders APRIL 16 & 17, 2010 Hotel Casa Del Mar 1910 Ocean Way Santa Monica, CA 90405

2 FACULTY COURSE DIRECTORS Marvin Bergsneider, MD Professor and Vice-Chair UCLA Department of Neurosurgery Co-Director, UCLA Pituitary Tumor Program Anthony Heaney, MD, PhD Associate Professor UCLA Division of Endocrinology and Department of Neurosurgery Co-Director, UCLA Pituitary Tumor Program Michael Yeh, MD Assistant Professor UCLA Department of Surgery Director, UCLA Endocrine Surgery Program GUEST FACULTY Gary Hammer, MD Associate Professor Department of Internal Medicine Division of Metabolism, Endocrinology and Diabetes Department of Molecular and Integrative Physiology Millie Schembechler Professor of Adrenal Cancer University of Michigan Ann Arbor, Michigan Laurence Katznelson, MD Associate Professor of Medicine and Neurosurgery Medical Director, Pituitary Center Stanford University School of Medicine Stanford, California James Yao, MD Associate Professor Deputy Chair Gastrointestinal Medical Oncology Department M.D. Anderson Cancer Center Houston, Texas UCLA FACULTY Ronald W. Busuttil, MD Professor and Executive Chair, Department of Surgery Chief, Division of Liver and Pancreas Transplantation Dumont Chair in Transplantation Surgery Johannes Czernin, MD Professor Department of Molecular and Medical Pharmacology James Farrell, MD Associate Professor of Medicine Director of Pancreaticobiliary Endoscopy Director Endoscopic Ultrasound Division of Digestive Diseases Stephen Kee, MD Associate Professor of Radiology Chief of Interventional Radiology Dorothy Martinez, MD Associate Clinical Professor of Medicine Division of Endocrinology, Diabetes and Hypertension Noriko Salamon, MD Associate Professor of Radiology Director of Neuroradiology Fellowship Program Division of Neuroradiology Michael T. Selch, MD Professor Department of Radiation Oncology Ronald S. Swerdloff, MD Professor of Medicine Chief, Division of Endocrinology Harbor-UCLA Medical Center William H. Yong, MD Associate Clinical Professor of Pathology Brain Tumor Translational Resource Neuro-Oncology Program and Department of Pathology and Laboratory Medicine

3 State-of-the-Art Management of Pituitary and Neuroendocrine Disorders FRIDAY, April 16, :00PM Welcome Anthony Heaney, Marvin Bergsneider, Michael Yeh 1:10 Establishing the Diagnosis of Cushing s Disease: Past, Present, and Future Anthony Heaney 1:40 State-of-the-Art Imaging of Pituitary Tumors Noriko Salamon 2:10 Practical Pituitary Pathology: Diagnoses the Endocrinologist Should Know William H. Yong 2:40 The Role of Stereotactic Irradiation for the Treatment of Pituitary Tumors Michael T. Selch 3:10 Break 3:30 High-Definition Endoscopic Pituitary Tumor Surgery - A New Era Marvin Bergsneider 4:00 Treating Pituitary Failure A Practical Approach Ronald S. Swerdloff 4:30 Controversies in the Medical Management of Acromegaly Laurence Katznelson 5:00 Panel Discussion: Q&A 5:50 Closing Remarks 6:00 Adjourn

4 SATURDAY, April 17, :30AM Breakfast 8:00 Introduction Anthony Heaney, Michael Yeh 8:10 Diagnostic Approach to NETs Anthony Heaney 8:40 New Age Gastroenterology Technologies in Carcinoid & Pancreatic NETs James Farrell 9:10 Molecular Imaging of Neuroendocrine Tumors Johannes Czernin 9:40 Break 10:00 Surgical Therapy & Liver Transplant for NETs Ronald W. Busuttil 10:30 Locoregional Approaches for Metastatic Endocrine Tumors Stephen Kee 11:00 Novel Therapeutics for Neuroendocrine Tumors James Yao 11:30 Panel Discussion: Q&A 12:00PM Lunch 1:00 Introduction Anthony Heaney, Michael Yeh 1:10 Differentiated Thyroid Cancer: Latest Oncologic Principles Michael Yeh 1:40 Long-Term Surveillance for Differentiated Thyroid Cancer Dorothy Martinez 2:10 Break 2:30 Minimally Invasive Parathyroid Surgery Michael Yeh 3:00 Novel Therapeutics for Adrenocortical Carcinoma Gary Hammer 3:30 Panel Discussion: Q&A 4:00 Closing Remarks Anthony Heaney, Marvin Bergsneider, Michael Yeh

5 PITUITARY & NEUROENDOCRINE DISORDERS COURSE COURSE# M Tuition: Physicians $ Nurses $ Fellows/Residents $ Please print clearly Specialty Degree Name (First,Middle,Last) Address City,State,Zip ( ) ( ) (Area Code) Business Phone (Area Code) Fax Number Address Last 4 digits of your Social Security Number Course Enrollment Options q Check enclosed, payable to: Academic Event Management q Please charge my credit card / Card Number Exp.Date Signature Mail completed enrollment form to: Academic Event Management 1396 Rancho Lane Thousand Oaks, CA Fax enrollment form to: Register by phone: Register by pat@academiceventmanagement.com Register on-line: REFUNDS: Cancellations must be received in writing by March 2, 2010 and will be subject to a $30 processing fee. No refunds will be given after that date. If for any reason the course must be canceled, discontinued, or rescheduled by the Office of CME, a full refund will be provided.

6 COURSE DESCRIPTION This one-and-a-half-day symposium covers key topics in pituitary and neuroendocrine tumors. Distinguished guest and UCLA faculty will provide comprehensive and authoritative lectures discussing current management guidelines, introducing recent advancements, and putting into perspective the latest research in the field. The course content will be applicable to practicing physicians, residents, and ancillary providers (nurse practitioners and physician assistants) caring for patients with pituitary and neuroendocrine tumors. Attendees will have the opportunity to ask questions and discuss cases with the faculty in interactive sessions. TARGET AUDIENCE Endocrinologists, Internal Medicine Physicians, Neurosurgeons, Endocrine Surgeons, Oncologists, General & Oncologic Surgeons, and Interventional Radiologists. COURSE OBJECTIVES At the conclusion of this activity, participants should be able to: 1. Describe key advances in the evaluation and management of pituitary, neuroendocrine and endocrine tumors that will affect clinical practice and will determine the direction of research in these fields in the coming years. 2. Review new imaging techniques in pituitary, neuroendocrine and endocrine tumors. 3. Manage the patient with Cushing s disease and acromegaly. 4. Discuss the role of radiology and pathology in the management of pituitary tumors. 5. Review the advances in surgical and radiosurgical techniques for pituitary tumors. 6. Discuss the laboratory and radiological evaluation of small bowel carcinoids and pancreatic neuroendocrine tumors 7. Identify which patients with IBD to investigate for carcinoid tumors. 8. Recognize importance of early detection of NETs. 9. Assess the clinical impact of new endoscopic modalities for diagnosis of GI neuroendocrine tumors. 10. Identify the patient with metastatic NET disease and understand the role of debulking surgery and liver transplantation. 11. Describe the long-term management of patients with thyroid cancer. 12. Recognize the etiology and management of hyperparathyroidism. 13. Understand recent advances in the management of adrenal tumors. ACCREDITATION The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this educational activity for a maximum of 10.5 AMA PRA Category 1 Credits TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. This CME activity meets the requirements, under California Assembly Bill 1195, continuing education and cultural and linguistic competency. Disclosure The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is truly independent and free of commercial influence. In addition to independence, the FDA requires that non-promotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program s participants. In addition, policy of the Accreditation Council for Continuing Medical Education now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA, fully endorse the letter and spirit of these concepts.

7 COURSE LOCATION Hotel Casa Del Mar 1910 Ocean Way Santa Monica, CA ACCOMMODATIONS Hotel Casa Del Mar 1910 Ocean Way Santa Monica, CA For reservations, call Mention UCLA Pituitary Course to get a special rate of $285 per night plus taxes. Cut-off date for this special rate is April 1, Parking is available at the hotel for a reduced price $14 per day $33 per night

8 Presorted First Class Mail U.S. Postage Paid Santa Ana, CA Permit # 61 State-of-the-Art Management of Pituitary and Neuroendocrine Disorders Office of Continuing Medical Education David Geffen School of Medicine at UCLA 405 Hilgard Avenue Box Los Angeles, CA Presented by: